2022
DOI: 10.1002/ame2.12278
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of animal models for COVID‐19

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19), the most consequential pandemic of this century, threatening human health and public safety. SARS‐CoV‐2 has been continuously evolving through mutation of its genome and variants of concern have emerged. The World Health Organization R&D Blueprint plan convened a range of expert groups to develop animal models for COVID‐19, a core requirement for the prevention and control of SARS‐CoV… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 112 publications
(178 reference statements)
0
4
0
Order By: Relevance
“…COVID-19 involves complex host-pathogen interactions; therefore, it is necessary to develop animal models that can provide measurable readouts for potential interventions ( Johansen et al, 2020 ; Muñoz-Fontela et al, 2020 ; Villano, 2021 ; Choudhary et al, 2022 ). To rapidly evaluate these potential medical countermeasures, such as therapeutic drugs and preventive vaccines, animal models that were susceptible to SARS-CoV-2 infection are invaluable ( Zeiss et al, 2021 ; Choudhary et al, 2022 ; Fan et al, 2022 ; Golden et al, 2022 ; Qi and Qin, 2022 ; Rizvi et al, 2022 ; Zhao et al, 2022 ). However, wild-type mice do not support SARS-CoV-2 replication due to the incompatibility of mouse ACE2 with the spike protein of SARS-CoV-2 ( Yang et al, 2007 ; Golden et al, 2020 ; Oladunni et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…COVID-19 involves complex host-pathogen interactions; therefore, it is necessary to develop animal models that can provide measurable readouts for potential interventions ( Johansen et al, 2020 ; Muñoz-Fontela et al, 2020 ; Villano, 2021 ; Choudhary et al, 2022 ). To rapidly evaluate these potential medical countermeasures, such as therapeutic drugs and preventive vaccines, animal models that were susceptible to SARS-CoV-2 infection are invaluable ( Zeiss et al, 2021 ; Choudhary et al, 2022 ; Fan et al, 2022 ; Golden et al, 2022 ; Qi and Qin, 2022 ; Rizvi et al, 2022 ; Zhao et al, 2022 ). However, wild-type mice do not support SARS-CoV-2 replication due to the incompatibility of mouse ACE2 with the spike protein of SARS-CoV-2 ( Yang et al, 2007 ; Golden et al, 2020 ; Oladunni et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6][7][8][9] This has been exten-sively described for pulmonary macrophages 10,11 but also for neutrophils, which contribute to disease severity through thrombotic complications caused by NETosis. 12,13 Animal models have been essential in the study of COVID-19 14,15 . Hamsters have been particularly useful as they can be readily infected by the same SARS-CoV-2 variants as humans.…”
Section: Introductionmentioning
confidence: 99%
“…Syrian hamsters have been widely used for COVID-19 research due to their susceptibility to SARS-CoV-2, and active transmission via aerosol and lung pathology resembling human infection [ 4 ]. Whilst intranasal delivery of the virus has been widely used for SARS-CoV-2 challenge studies [ 5 ], to refine the Syrian hamster model we have developed a natural transmission caging system, where donor animals challenged with SARS-CoV-2 are housed in a central cage and two adjacent cages house recipient animals, with airflow drawing across from the donor animal cage to the side cages [ 6 ]. Other natural transmission models for SARS-CoV-2 have also been reported.…”
Section: Introductionmentioning
confidence: 99%